134 related articles for article (PubMed ID: 24300182)
1. Atomic pairwise distribution function analysis of the amorphous phase prepared by different manufacturing routes.
Boetker JP; Koradia V; Rades T; Rantanen J; Savolainen M
Pharmaceutics; 2012 Jan; 4(1):93-103. PubMed ID: 24300182
[TBL] [Abstract][Full Text] [Related]
2. Quantification of Process Induced Disorder in Milled Samples Using Different Analytical Techniques.
Zimper U; Aaltonen J; McGoverin CM; Gordon KC; Krauel-Goellner K; Rades T
Pharmaceutics; 2010 Feb; 2(1):30-49. PubMed ID: 27721341
[TBL] [Abstract][Full Text] [Related]
3. Solid-state characterization of amorphous and mesomorphous calcium ketoprofen.
Atassi F; Mao C; Masadeh AS; Byrn SR
J Pharm Sci; 2010 Sep; 99(9):3684-97. PubMed ID: 19780126
[TBL] [Abstract][Full Text] [Related]
4. Polymorphic form of piroxicam influences the performance of amorphous material prepared by ball-milling.
Naelapää K; Boetker JP; Veski P; Rantanen J; Rades T; Kogermann K
Int J Pharm; 2012 Jun; 429(1-2):69-77. PubMed ID: 22433471
[TBL] [Abstract][Full Text] [Related]
5. Assessment of crystalline disorder in cryo-milled samples of indomethacin using atomic pair-wise distribution functions.
Bøtker JP; Karmwar P; Strachan CJ; Cornett C; Tian F; Zujovic Z; Rantanen J; Rades T
Int J Pharm; 2011 Sep; 417(1-2):112-9. PubMed ID: 21182911
[TBL] [Abstract][Full Text] [Related]
6. Better understanding of dissolution behaviour of amorphous drugs by in situ solid-state analysis using Raman spectroscopy.
Savolainen M; Kogermann K; Heinz A; Aaltonen J; Peltonen L; Strachan C; Yliruusi J
Eur J Pharm Biopharm; 2009 Jan; 71(1):71-9. PubMed ID: 18590816
[TBL] [Abstract][Full Text] [Related]
7. Toward understanding the evolution of griseofulvin crystal structure to a mesophase after cryogenic milling.
Feng T; Bates S; Carvajal MT
Int J Pharm; 2009 Feb; 367(1-2):16-9. PubMed ID: 19013224
[TBL] [Abstract][Full Text] [Related]
8. Influence of sample characteristics on quantification of carbamazepine hydrate formation by X-ray powder diffraction and Raman spectroscopy.
Tian F; Zhang F; Sandler N; Gordon KC; McGoverin CM; Strachan CJ; Saville DJ; Rades T
Eur J Pharm Biopharm; 2007 Jun; 66(3):466-74. PubMed ID: 17257816
[TBL] [Abstract][Full Text] [Related]
9. Effect of different preparation methods on the dissolution behaviour of amorphous indomethacin.
Karmwar P; Graeser K; Gordon KC; Strachan CJ; Rades T
Eur J Pharm Biopharm; 2012 Feb; 80(2):459-64. PubMed ID: 22019529
[TBL] [Abstract][Full Text] [Related]
10. Investigation of properties and recrystallisation behaviour of amorphous indomethacin samples prepared by different methods.
Karmwar P; Graeser K; Gordon KC; Strachan CJ; Rades T
Int J Pharm; 2011 Sep; 417(1-2):94-100. PubMed ID: 21182910
[TBL] [Abstract][Full Text] [Related]
11. Screening for differences in the amorphous state of indomethacin using multivariate visualization.
Savolainen M; Heinz A; Strachan C; Gordon KC; Yliruusi J; Rades T; Sandler N
Eur J Pharm Sci; 2007 Feb; 30(2):113-23. PubMed ID: 17169536
[TBL] [Abstract][Full Text] [Related]
12. X-ray powder diffractometry in combination with principal component analysis--a tool for monitoring solid state changes.
Kogermann K; Veski P; Rantanen J; Naelapää K
Eur J Pharm Sci; 2011 Jul; 43(4):278-89. PubMed ID: 21575718
[TBL] [Abstract][Full Text] [Related]
13. Study of the Microstructure of Amorphous Silica Nanostructures Using High-Resolution Electron Microscopy, Electron Energy Loss Spectroscopy, X-ray Powder Diffraction, and Electron Pair Distribution Function.
Khouchaf L; Boulahya K; Das PP; Nicolopoulos S; Kis VK; Lábár JL
Materials (Basel); 2020 Oct; 13(19):. PubMed ID: 33019776
[TBL] [Abstract][Full Text] [Related]
14. Unravelling the relationship between degree of disorder and the dissolution behavior of milled glibenclamide.
Mah PT; Laaksonen T; Rades T; Aaltonen J; Peltonen L; Strachan CJ
Mol Pharm; 2014 Jan; 11(1):234-42. PubMed ID: 24224572
[TBL] [Abstract][Full Text] [Related]
15. Quantitative solid-state analysis of three solid forms of ranitidine hydrochloride in ternary mixtures using Raman spectroscopy and X-ray powder diffraction.
Chieng N; Rehder S; Saville D; Rades T; Aaltonen J
J Pharm Biomed Anal; 2009 Jan; 49(1):18-25. PubMed ID: 19081220
[TBL] [Abstract][Full Text] [Related]
16. Effect of milling conditions on the solid-state conversion of ranitidine hydrochloride form 1.
Chieng N; Zujovic Z; Bowmaker G; Rades T; Saville D
Int J Pharm; 2006 Dec; 327(1-2):36-44. PubMed ID: 16949221
[TBL] [Abstract][Full Text] [Related]
17. The influence of thermal and mechanical preparative techniques on the amorphous state of four poorly soluble compounds.
Patterson JE; James MB; Forster AH; Lancaster RW; Butler JM; Rades T
J Pharm Sci; 2005 Sep; 94(9):1998-2012. PubMed ID: 16052554
[TBL] [Abstract][Full Text] [Related]
18. Relating hydrogen-bonding interactions with the phase behavior of naproxen/PVP K 25 solid dispersions: evaluation of solution-cast and quench-cooled films.
Paudel A; Nies E; Van den Mooter G
Mol Pharm; 2012 Nov; 9(11):3301-17. PubMed ID: 23009610
[TBL] [Abstract][Full Text] [Related]
19. Mapping the solid-state properties of crystalline lysozyme during pharmaceutical unit-operations.
Mohammad MA; Grimsey IM; Forbes RT
J Pharm Biomed Anal; 2015 Oct; 114():176-83. PubMed ID: 26068908
[TBL] [Abstract][Full Text] [Related]
20. Formation and physical stability of the amorphous phase of ranitidine hydrochloride polymorphs prepared by cryo-milling.
Chieng N; Rades T; Saville D
Eur J Pharm Biopharm; 2008 Mar; 68(3):771-80. PubMed ID: 17945474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]